Cromoglicic acid Other names: Sodium cromoglicate Cromolyn sodium Cromoglycate Cromoglicate Cromolyn Cromoglycate sodium

Chemical formula: C₂₃H₁₆O₁₁  Molecular mass: 468.367 g/mol  PubChem compound: 2882

Therapeutic indications

Cromoglicic acid is indicated for:

Seasonal and perennial allergic conjunctivitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

For the relief and treatment of seasonal and perennial allergic conjunctivitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bronchial asthma

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Cromoglicic acid is indicated for the preventative treatment of bronchial asthma, in adults and children.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Food allergy

Population group: only adults (18 years old or older)

Cromoglicic acid is indicated for food allergy (where adequate investigations have been performed to determine sensitivity to one or more ingested allergens) in conjunction with restriction of main causative allergens.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Food allergy

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Cromoglicic acid is indicated for food allergy (where adequate investigations have been performed to determine sensitivity to one or more ingested allergens) in conjunction with restriction of main causative allergens.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cromoglicic acid is contraindicated in the following cases:

Hypersensitivity to cromoglicic acid

Cromoglicic acid allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: INTAL CFC-FREE Pressurised inhalation, suspension
Summary of Product Characteristics (SPC) 2019: ALLERGY RELIEF Eye drops, Solution
Summary of Product Characteristics (SPC) 2015: NALCROM Capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈